Institutional Ownership Nls Pharmaceutics LTD Wt Pur C (NLSPW)
This table provides information about the institutional ownership of Nls Pharmaceutics LTD Wt Pur C (NLSPW). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 631,824 shares, which have been reported (via 13F filing form) to have a value of $6,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
200,000
shares
|
$2,000
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
170,100
shares
|
$1,701
0.64% of portfolio
|
Q4 2021
New holding
|
|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
150,000
shares
|
$1,500
0.23% of portfolio
|
Q1 2022
New holding
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
71,356
shares
|
$713
0.0% of portfolio
|
Q3 2024
Reduced 28.64%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
19,626
shares
|
$196
0.0% of portfolio
|
Q3 2024
Added 22.6%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
12,500
shares
|
$125
0.0% of portfolio
|
Q3 2024
Reduced 97.5%
|
|
|
Clear Street LLC
|
Nov 14, 2024 Q3 2024 |
8,242
shares
|
$82
0.0% of portfolio
|
Q3 2024
Reduced 0.35%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|